Nexentis Technologies (NXTS) Common Equity (2018 - 2026)
Nexentis Technologies' Common Equity was $1.91 million in Q2 2026, down 65.7% from $5.55 million a year earlier.
Powered by 
Analysis
Nexentis Technologies (NXTS) Common Equity (2018 - 2026) Analysis & Trends
At the end of FY2025, Common Equity at Nexentis Technologies came in at $16.01 million, up 250.1% from FY2024.
- In earlier years, Common Equity was $4.57 million in FY2024 (-29.2%), $6.46 million in FY2023 (+12.6%), $5.74 million in FY2022 (-10.5%) and $6.41 million in FY2021.
- The Q2 2026 figure marks the lowest quarterly Common Equity since Q1 2021.
- Compared with a year earlier, Common Equity was higher in three of the last seven quarters, with growth averaging 28.2%.
- The best year-over-year quarter for Common Equity over five years was Q4 2025 (growth of 250.1%); the worst was Q2 2026 (a decline of 65.7%).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Common Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 84.97 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | -5.94 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 41.98 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 41.95 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 50.37 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 11.69 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 11.83 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 85.49 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 20.25 Bn |
| 10 | Nexentis Technologies | 1.20 Mn | -21.57 Mn | - | 1.91 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.91 Mn |
| Dec 31, 2025 | 16.01 Mn |
| Sep 30, 2025 | 8.93 Mn |
| Jun 30, 2025 | 5.55 Mn |
| Mar 31, 2025 | 3.70 Mn |
| Dec 31, 2024 | 4.57 Mn |
| Sep 30, 2024 | 5.30 Mn |
| Jun 30, 2024 | 5.89 Mn |
| Mar 31, 2024 | 5.70 Mn |
| Dec 31, 2023 | 6.46 Mn |
| Sep 30, 2023 | 4.62 Mn |
| Jun 30, 2023 | 5.56 Mn |
| Mar 31, 2023 | 4.77 Mn |
| Dec 31, 2022 | 5.74 Mn |
| Sep 30, 2022 | 7.02 Mn |
| Jun 30, 2022 | 4.39 Mn |
| Mar 31, 2022 | 5.36 Mn |
| Dec 31, 2021 | 6.41 Mn |
| Sep 30, 2021 | 7.83 Mn |
| Jun 30, 2021 | 8.92 Mn |
API Access
Nexentis Technologies Common Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=common-equity&ticker=NXTS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "common-equity", "ticker": "NXTS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=common-equity&ticker=NXTS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();